# EDGAR Filing Document

**Accession Number:** 0001751788
**File Stem:** 0001751788-23-000008
**Filing Date:** 2023-1
**Character Count:** 59826
**Document Hash:** b14a5ef465277a1cea69a57ef4639ff0
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001751788-23-000008.hdr.sgml**: 20230126

**ACCESSION NUMBER**: 0001751788-23-000008

**CONFORMED SUBMISSION TYPE**: 8-K/A

**PUBLIC DOCUMENT COUNT**: 16

**CONFORMED PERIOD OF REPORT**: 20230126

**ITEM INFORMATION**: Results of Operations and Financial Condition

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20230126

**DATE AS OF CHANGE**: 20230126

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** DOW INC.
- **CENTRAL INDEX KEY:** 0001751788
- **STANDARD INDUSTRIAL CLASSIFICATION:** PLASTICS, MATERIALS, SYNTH RESINS & NONVULCAN ELASTOMERS [2821]
- **IRS NUMBER:** 301128146
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K/A
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-38646
- **FILM NUMBER:** 23556548

**BUSINESS ADDRESS:**
- **STREET 1:** 2211 H.H. DOW WAY
- **CITY:** MIDLAND
- **STATE:** MI
- **ZIP:** 48674
- **BUSINESS PHONE:** 9896361000

**MAIL ADDRESS:**
- **STREET 1:** 2211 H.H. DOW WAY
- **CITY:** MIDLAND
- **STATE:** MI
- **ZIP:** 48674

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Dow Inc.
- **DATE OF NAME CHANGE:** 20190305

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Dow Holdings Inc.
- **DATE OF NAME CHANGE:** 20180831

?xml version="1.0" ? dow-20230126

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 8-K/A** 

**(Amendment No. 1)**

**CURRENT REPORT**

**Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934**

**Date of Report (Date of earliest event reported):**

**January 26, 2023**![dow-20230126_g1.jpg](dow-20230126_g1.jpg)

---

| | | | |
|:---|:---|:---|:---|
| **Commission**<br>**<u>File Number</u>** | **Exact Name of Registrant as Specified in its Charter,**<br>**<u>Principal Office Address and Telephone Number</u>** | **State of Incorporation or**<br>**<u>Organization</u>** | **I.R.S. Employer**<br>**<u>Identification No.</u>** |
| 001-38646 | **Dow Inc.** | Delaware | 30-1128146 |
|  | 2211 H.H. Dow Way, Midland, MI 48674 |  |  |
|  | (989) 636-1000 |  |  |

---

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

◻&nbsp;&nbsp;&nbsp;&nbsp;Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

◻&nbsp;&nbsp;&nbsp;&nbsp;Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

◻&nbsp;&nbsp;&nbsp;&nbsp;Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

◻&nbsp;&nbsp;&nbsp;&nbsp;Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

---

| | | | |
|:---|:---|:---|:---|
| **Registrant** | **Title of each class** | **Trading Symbol(s)** | **Name of each exchange on which registered** |
| **Dow Inc.** | Common Stock, par value $0.01 per share | DOW | New York Stock Exchange |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ◻

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ◻

------

**Section 2 - Financial Information**

**Item 2.02 Results of Operations and Financial Condition.**

On January 26, 2023, Dow Inc. issued a press release, which was furnished as Exhibit 99.1 to the Current Report on Form 8-K filed with the U.S. Securities and Exchange Commission (the "Original Form 8-K"). Dow Inc. is filing this Amendment No. 1 on Form 8-K/A solely for the purpose of providing an updated copy of the press release correcting an inadvertent error reported in the Financial Highlights section relating to the Company's free cash flow. No other changes have been made to the Original Form 8-K or press release furnished therewith.

The reference to free cash flow in the eighth bullet under the Financial Highlights section in the press release should read "Free cash flow<sup>1</sup> was $1.5 billion" rather than "Free cash flow<sup>1</sup> was $1.5 million" as originally issued inadvertently.

Free cash flow is a Non-GAAP measure. Please refer to the referenced press release for the definition and reconciliation.

The press release was corrected on January 26, 2023, and is attached as Exhibit 99.1 and incorporated herein by reference.

The information contained in this report, including Exhibit 99.1 attached hereto, is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of Section 18. Furthermore, the information contained in this report shall not be deemed to be incorporated by reference into any registration statement or other document filed pursuant to the Securities Act of 1933, as amended.

**Section 9 - Financial Statements and Exhibits**

**Item 9.01 Financial Statements and Exhibits.**

(d)&nbsp;&nbsp;&nbsp;&nbsp;Exhibits. The exhibit listed on the Exhibit Index is incorporated herein by reference.

---

| | |
|:---|:---|
| Exhibit No. | Exhibit Description |
| <u>[99.1](exhibit991enrschedulesv24q.htm)</u> | Corrected press release issued by Dow Inc. on January 26, 2023, announcing results for the fourth quarter of 2022. |
| 104 | Cover Page Interactive Data File. The cover page interactive data file does not appear in the Interactive Data File because its XBRL tags are embedded with the Inline XBRL document. |

---

------

**Signature**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

DOW INC.

Date: January 26, 2023

---

| |
|:---|
| /s/ RONALD C. EDMONDS |
| Ronald C. Edmonds |
| Controller and Vice President of Controllers and Tax |

---

## Exhibit 99.1

![dow-seek_vertxsmbrandline.jpg](dow-seek_vertxsmbrandline.jpg)**Exhibit 99.1<br>January 26, 2023**

**Dow reports fourth quarter 2022 results**

**FINANCIAL HIGHLIGHTS**

• GAAP earnings per share (EPS) was $0.85; operating EPS<sup>1</sup> was $0.46, compared to $2.15 in the year-ago period and $1.11 in the prior quarter. Operating EPS excludes significant items in the quarter, totaling $0.39 per share, primarily due to the successful and final resolution and recognition of a long-running patent infringement award.

• Net sales were $11.9 billion, down 17% versus the year-ago period and 16% sequentially, reflecting declines in all operating segments driven by slower GDP growth and customer destocking.

• Local price declined 5% versus the year-ago period, driven by Packaging & Specialty Plastics. Sequentially, local price decreased 6% with declines in all operating segments and regions.

• Currency decreased net sales by 4% year-over-year and 1% versus the prior quarter, reflecting the impact of broad-based strength of the U.S. dollar.

• Volume decreased 8% versus the year-ago period, led by an 18% decline in Europe, the Middle East, Africa, and India (EMEAI), and destocking in building & construction and consumer durables end-markets in the U.S. & Canada. Sequentially, volume decreased by 9% with declines in all regions.

• Equity losses were $43 million, $267 million lower than the year-ago period, with declines at the Company's principal joint ventures. Equity earnings improved by $15 million from the prior quarter, due to improved earnings at the Thai and Sadara joint ventures.

• GAAP net income was $647 million. Operating EBIT<sup>1</sup> was $601 million, down $1.7 billion versus the year-ago period and down $594 million sequentially, with declines in all operating segments due to lower pricing and reduced operating rates to match market dynamics.

• Cash provided by operating activities – continuing operations was $2.1 billion, down $479 million year-over-year and up $138 million compared to the prior quarter. Free cash flow<sup>1</sup> was $1.5 billion.

• Returns to shareholders totaled $620 million in the quarter, including $495 million in dividends and $125 million in share repurchases.

• The Company delivered 2022 full year net sales of $56.9 billion, versus $55 billion in 2021. GAAP net income was $4.6 billion, versus $6.4 billion in 2021. Operating EBIT was $6.6 billion, versus $9.5 billion in 2021. Cash provided by operating activities – continuing operations was $7.5 billion, up from $7.1 billion in 2021. The Company delivered a cash flow conversion<sup>1</sup> of 80% and returns to shareholders totaled $4.3 billion, through $2.3 billion in share repurchases and $2 billion in dividends.

**SUMMARY FINANCIAL RESULTS**

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended Dec 31** | **Three Months Ended Dec 31** | **Three Months Ended Dec 31** | **Three Months Ended Sept 30** | **Three Months Ended Sept 30** |
| *In millions, except per share amounts* | **<u>4Q22</u>** | **<u>4Q21</u>** | **<u>vs. SQLY</u>**<br>**<u>[B / (W)]</u>** | **<u>3Q22</u>** | **<u>vs. PQ</u>**<br>**<u>[B / (W)]</u>** |
| **Net Sales** | $11859 | $14364 | $(2505) | $14115 | $(2256) |
| **GAAP Income, Net of Tax** | $647 | $1761 | $(1114) | $760 | $(113) |
| **Operating EBIT**<sup>1</sup> | $601 | $2265 | $(1664) | $1195 | $(594) |
| ***Operating EBIT Margin***<sup>1</sup> | *5.1 %* | *15.8 %* | *(1070) bps* | *8.5 %* | *(340) bps* |
| **Operating EBITDA**<sup>1</sup> | $1255 | $2920 | $(1665) | $1863 | $(608) |
| **GAAP Earnings Per Share** | $0.85 | $2.32 | $(1.47) | $1.02 | $(0.17) |
| **Operating Earnings Per Share**<sup>1</sup> | $0.46 | $2.15 | $(1.69) | $1.11 | $(0.65) |
| **Cash Provided by Operating Activities - Cont. Ops** | $2078 | $2557 | $(479) | $1940 | $138 |

---

1. Op. Earnings Per Share, Op. EBIT, Op. EBIT Margin, Op. EBITDA, and Free Cash Flow are non-GAAP measures. See page 6 for further discussion.®™ Trademark of The Dow Chemical Company ("Dow") or an affiliated company of Dow

------

Dow reports fourth quarter 2022 results

**CEO QUOTE**

Jim Fitterling, chairman and chief executive officer, commented on the quarter:

"In the fourth quarter, Team Dow continued to proactively navigate slowing global growth, challenging energy markets, and destocking. In response, we shifted our focus to cash generation in the quarter as we lowered operating rates, implemented cost savings measures, and prioritized higher-value products where demand remained resilient. These actions resulted in $2.1 billion of cash flow from operations.

"Dow's distinct competitive advantages and our operational and financial discipline enabled us to deliver resilient performance in 2022, despite a challenging second half of the year. For the year, we generated $7.5 billion of cash flow from operations – up more than $400 million year-over-year – and returned a total of $4.3 billion to our shareholders while continuing to advance our Decarbonize and Grow strategy. In addition, our ongoing higher-return, lower-risk, and faster-payback investments in our global operations will continue to create long-term shareholder value as we meet the growing customer demand for innovative and more sustainable solutions."<br>

**SEGMENT HIGHLIGHTS**

**Packaging & Specialty Plastics**

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended Dec 31** | **Three Months Ended Dec 31** | **Three Months Ended Dec 31** | **Three Months Ended Sept 30** | **Three Months Ended Sept 30** |
| *In millions, except margin percentages* | **<u>4Q22</u>** | **<u>4Q21</u>** | **<u>vs. SQLY</u>**<br>**<u>[B / (W)]</u>** | **<u>3Q22</u>** | **<u>vs. PQ</u>**<br>**<u>[B / (W)]</u>** |
| **Net Sales** | $6073 | $7189 | $(1116) | $7327 | $(1254) |
| **Operating EBIT** | $655 | $1442 | $(787) | $785 | $(130) |
| ***Operating EBIT Margin*** | *10.8 %* | *20.1 %* | *(930) bps* | *10.7 %* | *10 bps* |
| **Equity Earnings** | $56 | $130 | $(74) | $55 | $1 |

---

Packaging & Specialty Plastics segment net sales in the quarter were $6.1 billion, down 16% versus the year-ago period. Local price decreased 9% year-over-year, as gains across all regions in functional polymers were more than offset by lower polyethylene and olefin prices. Volume decreased 4% year-over-year, driven primarily by lower olefins and packaging demand in EMEAI, which was partly offset by continued resilience in demand for functional polymers. Currency decreased net sales by 3%. On a sequential basis, net sales decreased by 17%, driven by lower hydrocarbon sales and polyethylene local prices.

Equity earnings were $56 million, down $74 million compared to the year-ago period, primarily due to lower integrated polyethylene margins at the Company's principal joint ventures. Equity earnings were flat on a sequential basis.

Operating EBIT was $655 million, compared to $1.4 billion in the year-ago period, down primarily due to lower integrated polyethylene margins. Sequentially, Op. EBIT was down $130 million as lower raw material and energy costs were more than offset by lower polyethylene local prices and operating rates.

<u>Packaging and Specialty Plastics</u> business reported a net sales decrease versus the year-ago period, as local price and volume gains in functional polymers for renewable energy applications and mobility end-markets were more than offset by lower polyethylene prices and lower industrial and consumer packaging demand in EMEAI. Sequentially, net sales decreased on lower polyethylene local prices, partly offset by improving market demand dynamics in Asia Pacific.

<u>Hydrocarbons & Energy</u> business reported a net sales decrease compared to the year-ago period and sequentially, driven by lower olefin and aromatic sales in the U.S. & Canada and EMEAI.

------

Dow reports fourth quarter 2022 results

**Industrial Intermediates & Infrastructure**

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended Dec 31** | **Three Months Ended Dec 31** | **Three Months Ended Dec 31** | **Three Months Ended Sept 30** | **Three Months Ended Sept 30** |
| *In millions, except margin percentages* | **<u>4Q22</u>** | **<u>4Q21</u>** | **<u>vs. SQLY</u>**<br>**<u>[B / (W)]</u>** | **<u>3Q22</u>** | **<u>vs. PQ</u>**<br>**<u>[B / (W)]</u>** |
| **Net Sales** | $3653 | $4548 | $(895) | $4059 | $(406) |
| **Operating EBIT** | $164 | $595 | $(431) | $167 | $(3) |
| ***Operating EBIT Margin*** | *4.5 %* | *13.1 %* | *(860) bps* | *4.1 %* | *40 bps* |
| **Equity Earnings (Losses)** | $(96) | $90 | $(186) | $(114) | $18 |

---

Industrial Intermediates & Infrastructure segment net sales were $3.7 billion, down 20% versus the year-ago period. Local price decreased 1% year-over-year and currency decreased net sales by 5%. Volume was down 14% year-over-year, primarily driven by lower demand in EMEAI for industrial, consumer durables, and building & construction applications. On a sequential basis, the segment recorded a net sales decline of 10% as a seasonal increase in deicing fluid demand was more than offset by declines in building & construction, consumer durables, and industrial applications.

Equity losses for the segment were $96 million, a decrease of $186 million compared to the year-ago period driven by competitive pricing pressures in MEG and propylene oxide derivatives due to supply additions in China, as well as lower demand. On a sequential basis, equity earnings improved by $18 million, primarily due to improved earnings at Sadara.

Operating EBIT was $164 million, compared to $595 million in the year-ago period, driven by lower demand and increased energy costs particularly in EMEAI. On a sequential basis, operating EBIT margins expanded 40 basis points as lower energy costs versus the prior quarter were partly offset by lower volumes.

<u>Polyurethanes & Construction Chemicals</u> business reported a net sales decrease compared to the year-ago period, primarily driven by lower demand in EMEAI for consumer durables, industrial, and building & construction applications, as well as currency impacts. Sequentially, net sales declined due to value chain destocking and seasonality in building & construction.

<u>Industrial Solutions</u> business reported lower net sales compared to the year-ago period, as strong demand for pharmaceutical and energy applications was more than offset by lower volumes in coatings and industrial markets. Sequentially, net sales decreased as local price declines and lower demand in industrial end-markets were partly offset by a seasonal increase in deicing fluid demand.

**Performance Materials & Coatings**

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended Dec 31** | **Three Months Ended Dec 31** | **Three Months Ended Dec 31** | **Three Months Ended Sept 30** | **Three Months Ended Sept 30** |
| *In millions, except margin percentages* | **<u>4Q22</u>** | **<u>4Q21</u>** | **<u>vs. SQLY</u>**<br>**<u>[B / (W)]</u>** | **<u>3Q22</u>** | **<u>vs. PQ</u>**<br>**<u>[B / (W)]</u>** |
| **Net Sales** | $2058 | $2558 | $(500) | $2654 | $(596) |
| **Operating EBIT** | $(130) | $295 | $(425) | $302 | $(432) |
| ***Operating EBIT Margin*** | *(6.3) %* | *11.5 %* | *(1780) bps* | *11.4 %* | *(1770) bps* |
| **Equity Earnings** | $4 | $2 | $2 | $1 | $3 |

---

Performance Materials & Coatings segment net sales in the quarter were $2.1 billion, down 20% versus the year-ago period. Local price decreased 2% year-over-year, as price gains for performance silicones and architectural coatings were more than offset by lower pricing for siloxanes and acrylic monomers. Currency decreased net sales by 5%. Volume declined 13% year-over-year, as resilient demand in mobility was more than offset by declines primarily in building & construction end-markets. On a sequential basis, net sales were down 22% due to lower demand for coatings, industrial, and building & construction applications, as well as local price declines for siloxanes and acrylic monomers.

------

Dow reports fourth quarter 2022 results

Operating EBIT was a loss of $130 million, compared to earnings of $295 million in the year-ago period due to local price declines in siloxanes and acrylic monomers and lower operating rates in the quarter to align with end-market dynamics. Sequentially, Op. EBIT declined $432 million, driven by lower prices, demand and operating rates.

<u>Consumer Solutions</u> business reported a decrease in net sales versus the year-ago period, as local price gains for performance silicones applications were more than offset by lower demand and prices for siloxanes. Sequentially, net sales declined due to decreased demand in electronics and personal care end-markets, driven by year-end destocking in the value chain as well as lower demand and local prices for siloxanes.

<u>Coatings & Performance Monomers</u> business reported lower net sales compared to the year-ago period. Local price gains for architectural and industrial coatings were more than offset by price declines in acrylic monomers. Volume declined year-over-year on decreased demand for coatings applications in the U.S. & Canada and EMEAI, compounded by value chain restocking in the year-ago period. Sequentially, net sales declined primarily due to seasonally lower demand and value chain destocking for coatings applications in the U.S. & Canada and EMEAI.

**OUTLOOK**

"As we enter 2023, we remain focused on managing near-term dynamics while continuing to position the company for long-term value creation," said Fitterling. "While we see initial positive signs from moderating inflation in the U.S., improving outlook for energy in Europe, and re-opening in China, we continue to be prudent and proactive by implementing a playbook of targeted actions focused on optimizing labor and purchased service costs, reducing turnaround spending, and enhancing productivity. These actions are collectively expected to deliver $1 billion in cost savings. Going forward, we will continue to maintain our disciplined and balanced approach to capital allocation and focus on cash flow generation, while executing our strategic priorities for long-term sustainable and profitable growth."

**Conference Call**

Dow will host a live webcast of its fourth quarter earnings conference call with investors to discuss its results, business outlook and other matters today at 8:00 a.m. ET. The webcast and slide presentation that accompany the conference call will be posted on the events and presentations page of investors.dow.com.

**About Dow**

Dow (NYSE: DOW) combines global breadth; asset integration and scale; focused innovation and materials science expertise; leading business positions; and environmental, social and governance leadership to achieve profitable growth and help deliver a sustainable future. The Company's ambition is to become the most innovative, customer centric, inclusive and sustainable materials science company in the world. Dow's portfolio of plastics, industrial intermediates, coatings and silicones businesses delivers a broad range of differentiated, science-based products and solutions for its customers in high-growth market segments, such as packaging, infrastructure, mobility and consumer applications. Dow operates manufacturing sites in 31 countries and employs approximately 37,800 people. Dow delivered sales of approximately $57 billion in 2022. References to Dow or the Company mean Dow Inc. and its subsidiaries. For more information, please visit www.dow.com or follow @DowNewsroom on Twitter.

###

------

Dow reports fourth quarter 2022 results

For further information, please contact:

---

| | |
|:---|:---|
| **Investors:** | **Media:** |
| Pankaj Gupta | Kyle Bandlow |
| pgupta@dow.com | kbandlow@dow.com |
| +1 989-638-5265 | +1 989-638-2417 |

---

**Cautionary Statement about Forward-Looking Statements** 

Certain statements in this press release are "forward-looking statements" within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements often address expected future business and financial performance, financial condition, and other matters, and often contain words or phrases such as "anticipate," "believe," "estimate," "expect," "intend," "may," "opportunity," "outlook," "plan," "project," "seek," "should," "strategy," "target," "will," "will be," "will continue," "will likely result," "would" and similar expressions, and variations or negatives of these words or phrases.

Forward-looking statements are based on current assumptions and expectations of future events that are subject to risks, uncertainties and other factors that are beyond Dow's control, which may cause actual results to differ materially from those projected, anticipated or implied in the forward-looking statements and speak only as of the date the statements were made. These factors include, but are not limited to: sales of Dow's products; Dow's expenses, future revenues and profitability; the continuing global and regional economic impacts of the coronavirus disease 2019 ("COVID-19") pandemic and other public health-related risks and events on Dow's business; any sanction, export restrictions, supply chain disruptions or increased economic uncertainty related to the ongoing conflict between Russia and Ukraine; capital requirements and need for and availability of financing; unexpected barriers in the development of technology, including with respect to Dow's contemplated capital and operating projects; Dow's ability to realize its commitment to carbon neutrality on the contemplated timeframe; size of the markets for Dow's products and services and ability to compete in such markets; failure to develop and market new products and optimally manage product life cycles; the rate and degree of market acceptance of Dow's products; significant litigation and environmental matters and related contingencies and unexpected expenses; the success of competing technologies that are or may become available; the ability to protect Dow's intellectual property in the United States and abroad; developments related to contemplated restructuring activities and proposed divestitures or acquisitions such as workforce reduction, manufacturing facility and/or asset closure and related exit and disposal activities, and the benefits and costs associated with each of the foregoing; fluctuations in energy and raw material prices; management of process safety and product stewardship; changes in relationships with Dow's significant customers and suppliers; changes in consumer preferences and demand; changes in laws and regulations, political conditions or industry development; global economic and capital markets conditions, such as inflation, market uncertainty, interest and currency exchange rates, and equity and commodity prices; business or supply disruptions; security threats, such as acts of sabotage, terrorism or war including the ongoing conflict between Russia and Ukraine; weather events and natural disasters; and disruptions in Dow's information technology networks and systems; and risks related to Dow's separation from DowDuPont Inc. such as Dow's obligation to indemnify DuPont de Nemours, Inc. and/or Corteva, Inc. for certain liabilities.

Where, in any forward-looking statement, an expectation or belief as to future results or events is expressed, such expectation or belief is based on the current plans and expectations of management and expressed in good faith and believed to have a reasonable basis, but there can be no assurance that the expectation or belief will result or be achieved or accomplished. A detailed discussion of principal risks and uncertainties which may cause actual results and events to differ materially from such forward-looking statements is included in the section titled "Risk Factors" contained in the Company's Annual Report on Form 10-K for the year ended December 31, 2021 and the Company's subsequent Quarterly Reports on Form 10-Q. These are not the only risks and uncertainties that Dow faces. There may be other risks and uncertainties that Dow is unable to identify at this time or that Dow does not currently expect to have a material impact on its business. If any of those risks or uncertainties develops into an actual event, it could have a material adverse effect on Dow's business. Dow Inc. and TDCC assume no obligation to update or revise publicly any forward-looking statements whether because of new information, future events, or otherwise, except as required by securities and other applicable laws.

<sup>®TM</sup> Trademark of The Dow Chemical Company ("Dow") or an affiliated company of Dow

------

**Non-GAAP Financial Measures**

This earnings release includes information that does not conform to U.S. GAAP and are considered non-GAAP measures. Management uses these measures internally for planning, forecasting and evaluating the performance of the Company's segments, including allocating resources. Dow's management believes that these non-GAAP measures best reflect the ongoing performance of the Company during the periods presented and provide more relevant and meaningful information to investors as they provide insight with respect to ongoing operating results of the Company and a more useful comparison of year-over-year results. These non-GAAP measures supplement the Company's U.S. GAAP disclosures and should not be viewed as alternatives to U.S. GAAP measures of performance. Furthermore, such non-GAAP measures may not be consistent with similar measures provided or used by other companies. Non-GAAP measures included in this release are defined below. Reconciliations for these non-GAAP measures to U.S. GAAP are provided in the Selected Financial Information and Non-GAAP Measures section starting on page 11. Dow does not provide forward-looking U.S. GAAP financial measures or a reconciliation of forward-looking non-GAAP financial measures to the most comparable U.S. GAAP financial measures on a forward-looking basis because the Company is unable to predict with reasonable certainty the ultimate outcome of pending litigation, unusual gains and losses, foreign currency exchange gains or losses and potential future asset impairments, as well as discrete taxable events, without unreasonable effort. These items are uncertain, depend on various factors, and could have a material impact on U.S. GAAP results for the guidance period.

Operating Earnings Per Share is defined as "Earnings per common share - diluted" excluding the after-tax impact of significant items.

Operating EBIT is defined as earnings (i.e., "Income before income taxes") before interest, excluding the impact of significant items.

Operating EBIT Margin is defined as Operating EBIT as a percentage of net sales.

Operating EBITDA is defined as earnings (i.e., "Income before income taxes") before interest, depreciation and amortization, excluding the impact of significant items.

Free Cash Flow is defined as "Cash provided by operating activities - continuing operations," less capital expenditures. Under this definition, Free Cash Flow represents the cash generated by the Company from operations after investing in its asset base. Free Cash Flow, combined with cash balances and other sources of liquidity, represent the cash available to fund obligations and provide returns to shareholders. Free Cash Flow is an integral financial measure used in the Company's financial planning process.

Cash Flow Conversion is defined as "Cash provided by operating activities - continuing operations," divided by Operating EBITDA. Management believes Cash Flow Conversion is an important financial metric as it helps the Company determine how efficiently it is converting its earnings into cash flow.

Operating Return on Invested Capital ("ROC") is defined as net operating profit after tax, excluding the impact of significant items, divided by total average capital, also referred to as ROIC.

------

**Dow Inc. and Subsidiaries**

**Consolidated Statements of Income**

---

| | | | | |
|:---|:---|:---|:---|:---|
| In millions, except per share amounts (Unaudited) | *Three Months Ended* | *Three Months Ended* | *Twelve Months Ended* | *Twelve Months Ended* |
| In millions, except per share amounts (Unaudited) | *Dec 31, 2022* | *Dec 31, 2021* | *Dec 31, 2022* | *Dec 31, 2021* |
| Net sales | $11859 | $14364 | $56902 | $54968 |
| &nbsp;&nbsp;&nbsp;&nbsp;Cost of sales | 10656 | 11778 | 48338 | 44191 |
| &nbsp;&nbsp;&nbsp;&nbsp;Research and development expenses | 225 | 225 | 851 | 857 |
| &nbsp;&nbsp;&nbsp;&nbsp;Selling, general and administrative expenses | 386 | 436 | 1675 | 1645 |
| &nbsp;&nbsp;&nbsp;&nbsp;Amortization of intangibles | 80 | 87 | 336 | 388 |
| &nbsp;&nbsp;&nbsp;&nbsp;Restructuring and asset related charges (credits) - net | (68) | (16) | 118 | 6 |
| &nbsp;&nbsp;&nbsp;&nbsp;Equity in earnings (losses) of nonconsolidated affiliates | (43) | 224 | 268 | 975 |
| &nbsp;&nbsp;&nbsp;&nbsp;Sundry income (expense) - net | 435 | 190 | 727 | (35) |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest income | 68 | 20 | 173 | 55 |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest expense and amortization of debt discount | 175 | 170 | 662 | 731 |
| Income before income taxes | 865 | 2118 | 6090 | 8145 |
| &nbsp;&nbsp;&nbsp;&nbsp;Provision for income taxes | 218 | 357 | 1450 | 1740 |
| Net income | 647 | 1761 | 4640 | 6405 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net income attributable to noncontrolling interests | 34 | 25 | 58 | 94 |
| Net income available for Dow Inc. common stockholders | $613 | $1736 | $4582 | $6311 |
| Per common share data: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Earnings per common share - basic | $0.86 | $2.34 | $6.32 | $8.44 |
| &nbsp;&nbsp;&nbsp;&nbsp;Earnings per common share - diluted | $0.85 | $2.32 | $6.28 | $8.38 |
| Weighted-average common shares outstanding - basic | 709.2 | 738.1 | 721.0 | 743.6 |
| Weighted-average common shares outstanding - diluted | 713.0 | 743.3 | 725.6 | 749.0 |

---

------

**Dow Inc. and Subsidiaries**

**Consolidated Balance Sheets**

---

| | | |
|:---|:---|:---|
| In millions, except share amounts (Unaudited) | *Dec 31,<br>2022* | *Dec 31,<br>2021* |
| **Assets** |  |  |
| Current Assets |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash and cash equivalents | $3886 | $2988 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accounts and notes receivable: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Trade (net of allowance for doubtful receivables - 2022: $110; 2021: $54) | 5611 | 6841 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other | 2144 | 2713 |
| &nbsp;&nbsp;&nbsp;&nbsp;Inventories | 6988 | 7372 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other current assets | 1848 | 934 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total current assets | 20477 | 20848 |
| Investments |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Investment in nonconsolidated affiliates | 1589 | 2045 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other investments (investments carried at fair value - 2022: $1,757; 2021: $2,079) | 2793 | 3193 |
| &nbsp;&nbsp;&nbsp;&nbsp;Noncurrent receivables | 666 | 478 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total investments | 5048 | 5716 |
| Property |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Property | 58055 | 57604 |
| &nbsp;&nbsp;&nbsp;&nbsp;Less: Accumulated depreciation | 37613 | 37049 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net property | 20442 | 20555 |
| Other Assets |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Goodwill | 8644 | 8764 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other intangible assets (net of accumulated amortization - 2022: $5,022; 2021: $4,725) | 2442 | 2881 |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating lease right-of-use assets | 1227 | 1412 |
| &nbsp;&nbsp;&nbsp;&nbsp;Deferred income tax assets | 960 | 1358 |
| &nbsp;&nbsp;&nbsp;&nbsp;Deferred charges and other assets | 1363 | 1456 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total other assets | 14636 | 15871 |
| Total Assets | $60603 | $62990 |
| **Liabilities and Equity** |  |  |
| Current Liabilities |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Notes payable | $362 | $161 |
| &nbsp;&nbsp;&nbsp;&nbsp;Long-term debt due within one year | 362 | 231 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accounts payable: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Trade | 4940 | 5577 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other | 2276 | 2839 |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating lease liabilities - current | 287 | 314 |
| &nbsp;&nbsp;&nbsp;&nbsp;Income taxes payable | 334 | 623 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accrued and other current liabilities | 2770 | 3481 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total current liabilities | 11331 | 13226 |
| Long-Term Debt | 14698 | 14280 |
| Other Noncurrent Liabilities |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Deferred income tax liabilities | 1110 | 506 |
| &nbsp;&nbsp;&nbsp;&nbsp;Pension and other postretirement benefits - noncurrent | 3808 | 7557 |
| &nbsp;&nbsp;&nbsp;&nbsp;Asbestos-related liabilities - noncurrent | 857 | 931 |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating lease liabilities - noncurrent | 997 | 1149 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other noncurrent obligations | 6555 | 6602 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total other noncurrent liabilities | 13327 | 16745 |
| Stockholders' Equity |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Common stock (authorized 5,000,000,000 shares of $0.01 par value each;<br>issued 2022: 771,678,525 shares; 2021: 764,226,882 shares) | 8 | 8 |
| &nbsp;&nbsp;&nbsp;&nbsp;Additional paid-in capital | 8540 | 8151 |
| &nbsp;&nbsp;&nbsp;&nbsp;Retained earnings | 23180 | 20623 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accumulated other comprehensive loss | (7139) | (8977) |
| &nbsp;&nbsp;&nbsp;&nbsp;Unearned ESOP shares |  | (15) |
| &nbsp;&nbsp;&nbsp;&nbsp;Treasury stock at cost (2022: 66,798,605 shares; 2021: 29,011,573 shares) | (3871) | (1625) |
| &nbsp;&nbsp;&nbsp;&nbsp;Dow Inc.'s stockholders' equity | 20718 | 18165 |
| &nbsp;&nbsp;&nbsp;&nbsp;Noncontrolling interests | 529 | 574 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total equity | 21247 | 18739 |
| Total Liabilities and Equity | $60603 | $62990 |

---

------

**Dow Inc. and Subsidiaries**

**Consolidated Statements of Cash Flows**

---

| | | |
|:---|:---|:---|
| In millions (Unaudited) For the years ended Dec 31, | *2022* | *2021* |
| Operating Activities |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net income | $4640 | $6405 |
| &nbsp;&nbsp;&nbsp;&nbsp;Adjustments to reconcile net income to net cash provided by operating activities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization | 2758 | 2842 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Provision for deferred income tax | 79 | 278 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Earnings of nonconsolidated affiliates less than (in excess of) dividends received | 696 | (651) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net periodic pension benefit cost | 23 | 39 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pension contributions | (235) | (1219) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net gain on sales of assets, businesses and investments | (19) | (105) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Restructuring and asset related charges - net | 118 | 6 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other net loss | 212 | 921 |
| &nbsp;&nbsp;&nbsp;&nbsp;Changes in assets and liabilities, net of effects of acquired and divested companies: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts and notes receivable | 1187 | (2132) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Inventories | 347 | (1768) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts payable | (1255) | 2458 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other assets and liabilities, net | (1065) | (5) |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash provided by operating activities - continuing operations | 7486 | 7069 |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash used for operating activities - discontinued operations | (11) | (60) |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash provided by operating activities | 7475 | 7009 |
| Investing Activities |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Capital expenditures | (1823) | (1501) |
| &nbsp;&nbsp;&nbsp;&nbsp;Investment in gas field developments | (190) | (92) |
| &nbsp;&nbsp;&nbsp;&nbsp;Purchases of previously leased assets | (7) | (694) |
| &nbsp;&nbsp;&nbsp;&nbsp;Proceeds from sales of property and businesses, net of cash divested | 32 | 68 |
| &nbsp;&nbsp;&nbsp;&nbsp;Acquisitions of property and businesses, net of cash acquired | (228) | (129) |
| &nbsp;&nbsp;&nbsp;&nbsp;Investments in and loans to nonconsolidated affiliates | (148) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Distributions and loan repayments from nonconsolidated affiliates | 52 | 51 |
| &nbsp;&nbsp;&nbsp;&nbsp;Proceeds from sales of ownership interests in nonconsolidated affiliates | 11 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Purchases of investments | (1366) | (1366) |
| &nbsp;&nbsp;&nbsp;&nbsp;Proceeds from sales and maturities of investments | 747 | 759 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other investing activities, net | (50) | (10) |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash used for investing activities | (2970) | (2914) |
| Financing Activities |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Changes in short-term notes payable | 253 | (48) |
| &nbsp;&nbsp;&nbsp;&nbsp;Proceeds from issuance of short-term debt greater than three months |  | 144 |
| &nbsp;&nbsp;&nbsp;&nbsp;Payments on short-term debt greater than three months | (14) | (130) |
| &nbsp;&nbsp;&nbsp;&nbsp;Proceeds from issuance of long-term debt | 1667 | 109 |
| &nbsp;&nbsp;&nbsp;&nbsp;Payments on long-term debt | (1006) | (2771) |
| &nbsp;&nbsp;&nbsp;&nbsp;Purchases of treasury stock | (2325) | (1000) |
| &nbsp;&nbsp;&nbsp;&nbsp;Proceeds from issuance of stock | 212 | 320 |
| &nbsp;&nbsp;&nbsp;&nbsp;Transaction financing, debt issuance and other costs | (24) | (537) |
| &nbsp;&nbsp;&nbsp;&nbsp;Employee taxes paid for share-based payment arrangements | (35) | (12) |
| &nbsp;&nbsp;&nbsp;&nbsp;Distributions to noncontrolling interests | (83) | (73) |
| &nbsp;&nbsp;&nbsp;&nbsp;Dividends paid to stockholders | (2006) | (2073) |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash used for financing activities | (3361) | (6071) |
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | (237) | (99) |
| Summary |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Increase (decrease) in cash, cash equivalents and restricted cash | 907 | (2075) |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash, cash equivalents and restricted cash at beginning of year | 3033 | 5108 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cash, cash equivalents and restricted cash at end of year | $3940 | $3033 |
| &nbsp;&nbsp;&nbsp;&nbsp;Less: Restricted cash and cash equivalents, included in "Other current assets" | 54 | 45 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cash and cash equivalents at end of year | $3886 | $2988 |

---

------

**Dow Inc. and Subsidiaries**

**Net Sales by Segment and Geographic Region**

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Net Sales by Segment** | *Three Months Ended* | *Three Months Ended* | *Twelve Months Ended* | *Twelve Months Ended* |
| In millions (Unaudited) | *Dec 31, 2022* | *Dec 31, 2021* | *Dec 31, 2022* | *Dec 31, 2021* |
| Packaging & Specialty Plastics | $6073 | $7189 | $29260 | $28128 |
| Industrial Intermediates & Infrastructure | 3653 | 4548 | 16606 | 16851 |
| Performance Materials & Coatings | 2058 | 2558 | 10764 | 9672 |
| Corporate | 75 | 69 | 272 | 317 |
| Total | $11859 | $14364 | $56902 | $54968 |
| U.S. & Canada | $4367 | $5182 | $20945 | $19613 |
| EMEAI <sup>1</sup> | 3808 | 5086 | 19631 | 19746 |
| Asia Pacific | 2347 | 2620 | 10344 | 10043 |
| Latin America | 1337 | 1476 | 5982 | 5566 |
| Total | $11859 | $14364 | $56902 | $54968 |

---

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Net Sales Variance by Segment and Geographic Region** | *Three Months Ended Dec 31, 2022* | *Three Months Ended Dec 31, 2022* | *Three Months Ended Dec 31, 2022* | *Three Months Ended Dec 31, 2022* | *Twelve Months Ended Dec 31, 2022* | *Twelve Months Ended Dec 31, 2022* | *Twelve Months Ended Dec 31, 2022* | *Twelve Months Ended Dec 31, 2022* |
| **Net Sales Variance by Segment and Geographic Region** | *Local Price & Product Mix* | *Currency* | *Volume* | *Total* | *Local Price & Product Mix* | *Currency* | *Volume* | *Total* |
| Percent change from prior year | *Local Price & Product Mix* | *Currency* | *Volume* | *Total* | *Local Price & Product Mix* | *Currency* | *Volume* | *Total* |
| Packaging & Specialty Plastics | (9)% | (3)% | (4)% | (16)% | 7% | (3)% | —% | 4% |
| Industrial Intermediates & Infrastructure | (1) | (5) | (14) | (20) | 11 | (5) | (7) | (1) |
| Performance Materials & Coatings | (2) | (5) | (13) | (20) | 21 | (4) | (6) | 11 |
| Total | (5)% | (4)% | (8)% | (17)% | 11% | (4)% | (3)% | 4% |
| Total, excluding the Hydrocarbons & Energy business | (4)% | (4)% | (9)% | (17)% | 10% | (4)% | (5)% | 1% |
| U.S. & Canada | (7)% | —% | (9)% | (16)% | 6% | —% | 1% | 7% |
| EMEAI <sup>1</sup> | 1 | (8) | (18) | (25) | 18 | (9) | (10) | (1) |
| Asia Pacific | (10) | (5) | 5 | (10) | 6 | (3) |  | 3 |
| Latin America | (8) |  | (1) | (9) | 6 |  | 1 | 7 |
| Total | (5)% | (4)% | (8)% | (17)% | 11% | (4)% | (3)% | 4% |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Net Sales Variance by Segment and Geographic Region** | *Three Months Ended Dec 31, 2022* | *Three Months Ended Dec 31, 2022* | *Three Months Ended Dec 31, 2022* | *Three Months Ended Dec 31, 2022* |
| **Net Sales Variance by Segment and Geographic Region** | *Local Price & Product Mix* | *Currency* | *Volume* | *Total* |
| Percent change from prior quarter | *Local Price & Product Mix* | *Currency* | *Volume* | *Total* |
| Packaging & Specialty Plastics | (9)% | (1)% | (7)% | (17)% |
| Industrial Intermediates & Infrastructure | (2) | (1) | (7) | (10) |
| Performance Materials & Coatings | (6) | (1) | (15) | (22) |
| Total | (6)% | (1)% | (9)% | (16)% |
| Total, excluding the Hydrocarbons & Energy business | (6)% | (1)% | (6)% | (13)% |
| U.S. & Canada | (7)% | —% | (11)% | (18)% |
| EMEAI <sup>1</sup> | (5) | (1) | (12) | (18) |
| Asia Pacific | (6) | (2) | (1) | (9) |
| Latin America | (9) |  | (6) | (15) |
| Total | (6)% | (1)% | (9)% | (16)% |

---

1. Europe, Middle East, Africa, and India.

------

**Dow Inc. and Subsidiaries**

**Selected Financial Information and Non-GAAP Measures**

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Operating EBIT by Segment** |  | *Three Months Ended* | *Three Months Ended* | *Twelve Months Ended* | *Twelve Months Ended* |
| In millions (Unaudited) |  | *Dec 31, 2022* | *Dec 31, 2021* | *Dec 31, 2022* | *Dec 31, 2021* |
| Packaging & Specialty Plastics |  | $655 | $1442 | $4110 | $6638 |
| Industrial Intermediates & Infrastructure |  | 164 | 595 | 1418 | 2282 |
| Performance Materials & Coatings |  | (130) | 295 | 1328 | 866 |
| Corporate |  | (88) | (67) | (266) | (253) |
| Total |  | $601 | $2265 | $6590 | $9533 |
| **Depreciation and Amortization by Segment** |  | *Three Months Ended* | *Three Months Ended* | *Twelve Months Ended* | *Twelve Months Ended* |
| In millions (Unaudited) |  | *Dec 31, 2022* | *Dec 31, 2021* | *Dec 31, 2022* | *Dec 31, 2021* |
| Packaging & Specialty Plastics |  | $320 | $316 | $1396 | $1358 |
| Industrial Intermediates & Infrastructure |  | 132 | 131 | 550 | 612 |
| Performance Materials & Coatings |  | 197 | 200 | 789 | 842 |
| Corporate |  | 5 | 8 | 23 | 30 |
| Total |  | $654 | $655 | $2758 | $2842 |
| **Operating EBITDA by Segment** |  | *Three Months Ended* | *Three Months Ended* | *Twelve Months Ended* | *Twelve Months Ended* |
| In millions (Unaudited) |  | *Dec 31, 2022* | *Dec 31, 2021* | *Dec 31, 2022* | *Dec 31, 2021* |
| Packaging & Specialty Plastics |  | $975 | $1758 | $5506 | $7996 |
| Industrial Intermediates & Infrastructure |  | 296 | 726 | 1968 | 2894 |
| Performance Materials & Coatings |  | 67 | 495 | 2117 | 1708 |
| Corporate |  | (83) | (59) | (243) | (223) |
| Total |  | $1255 | $2920 | $9348 | $12375 |
| **Equity in Earnings (Losses) of Nonconsolidated Affiliates by Segment** |  | *Three Months Ended* | *Three Months Ended* | *Twelve Months Ended* | *Twelve Months Ended* |
| In millions (Unaudited) |  | *Dec 31, 2022* | *Dec 31, 2021* | *Dec 31, 2022* | *Dec 31, 2021* |
| Packaging & Specialty Plastics |  | $56 | $130 | $359 | $490 |
| Industrial Intermediates & Infrastructure |  | (96) | 90 | (91) | 471 |
| Performance Materials & Coatings |  | 4 | 2 | 10 | 7 |
| Corporate |  | (7) | 2 | (10) | 7 |
| Total |  | $(43) | $224 | $268 | $975 |
| **Reconciliation of "Net Income" to "Operating EBIT"** | *Three Months Ended* | *Three Months Ended* | *Three Months Ended* | *Twelve Months Ended* | *Twelve Months Ended* |
| In millions (Unaudited) | *Sep 30, 2022* | *Dec 31, 2022* | *Dec 31, 2021* | *Dec 31, 2022* | *Dec 31, 2021* |
| Net income | $760 | $647 | $1761 | $4640 | $6405 |
| &nbsp;&nbsp;&nbsp;&nbsp;+ Provision for income taxes | 241 | 218 | 357 | 1450 | 1740 |
| Income before income taxes | $1001 | $865 | $2118 | $6090 | $8145 |
| &nbsp;&nbsp;&nbsp;&nbsp;- Interest income | 41 | 68 | 20 | 173 | 55 |
| &nbsp;&nbsp;&nbsp;&nbsp;+ Interest expense and amortization of debt discount | 155 | 175 | 170 | 662 | 731 |
| &nbsp;&nbsp;&nbsp;&nbsp;- Significant items | (80) | 371 | 3 | (11) | (712) |
| Operating EBIT (non-GAAP) | $1195 | $601 | $2265 | $6590 | $9533 |

---

------

**Dow Inc. and Subsidiaries**

**Selected Financial Information and Non-GAAP Measures**

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Significant Items Impacting Results for the Three Months Ended Dec 31, 2022** | **Significant Items Impacting Results for the Three Months Ended Dec 31, 2022** | **Significant Items Impacting Results for the Three Months Ended Dec 31, 2022** | **Significant Items Impacting Results for the Three Months Ended Dec 31, 2022** | **Significant Items Impacting Results for the Three Months Ended Dec 31, 2022** |
| In millions, except per share amounts (Unaudited) | *Pretax* <sup>1</sup> | *Net Income* <sup>2</sup> | *EPS* <sup>3</sup> | *Income Statement Classification* |
| Reported results | $865 | $613 | $0.85 |  |
| Less: Significant items |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Digitalization program costs <sup>4</sup> | (76) | (64) | (0.09) | Cost of sales ($62 million); R&D ($2 million); SG&A ($12 million) |
| &nbsp;&nbsp;&nbsp;Restructuring, implementation costs and asset related charges - net <sup>5</sup> | (9) | (7) | (0.01) | Cost of sales ($7 million); R&D ($1 million); SG&A ($1 million) |
| &nbsp;&nbsp;&nbsp;Russia / Ukraine conflict charges <sup>6</sup> | 68 | 56 | 0.08 | Restructuring and asset related charges - net |
| &nbsp;&nbsp;&nbsp;Litigation related charges, awards and adjustments <sup>7</sup> | 381 | 288 | 0.40 | Sundry income (expense) - net |
| &nbsp;&nbsp;&nbsp;Indemnifications and other transaction related costs <sup>8</sup> | 7 | 7 | 0.01 | Sundry income (expense) - net |
| &nbsp;&nbsp;&nbsp;&nbsp;Total significant items | $371 | $280 | $0.39 |  |
| Operating results (non-GAAP) | $494 | $333 | $0.46 |  |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Significant Items Impacting Results for the Three Months Ended Dec 31, 2021** | **Significant Items Impacting Results for the Three Months Ended Dec 31, 2021** | **Significant Items Impacting Results for the Three Months Ended Dec 31, 2021** | **Significant Items Impacting Results for the Three Months Ended Dec 31, 2021** | **Significant Items Impacting Results for the Three Months Ended Dec 31, 2021** |
| In millions, except per share amounts (Unaudited) | *Pretax* <sup>1</sup> | *Net Income* <sup>2</sup> | *EPS* <sup>3</sup> | *Income Statement Classification* |
| Reported results | $2118 | $1736 | $2.32 |  |
| Less: Significant items |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Digitalization program costs <sup>4</sup> | (48) | (38) | (0.05) | Cost of sales ($40 million); R&D ($2 million); SG&A ($6 million) |
| &nbsp;&nbsp;&nbsp;Restructuring, implementation costs and asset related credits - net <sup>5</sup> |  |  |  | Cost of sales ($11 million); R&D ($3 million); SG&A ($2 million); offset by Restructuring, goodwill impairment and asset related charges - net $16 million |
| &nbsp;&nbsp;&nbsp;&nbsp;Net gain on divestiture and asset sale | 16 | 16 | 0.02 | Sundry income (expense) - net |
| &nbsp;&nbsp;&nbsp;Indemnification and other transaction related costs <sup>8</sup> | 35 | 35 | 0.05 | Sundry income (expense) - net |
| &nbsp;&nbsp;&nbsp;Income tax related items <sup>9</sup> |  | 111 | 0.15 | Provision for income taxes on continuing operations |
| &nbsp;&nbsp;&nbsp;&nbsp;Total significant items | $3 | $124 | $0.17 |  |
| Operating results (non-GAAP) | $2115 | $1612 | $2.15 |  |

---

1."Income before income taxes."

2."Net income available for Dow Inc. common stockholders." The income tax effect on significant items was calculated based upon the enacted tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment.

3."Earnings per common share - diluted," which includes the impact of participating securities in accordance with the two-class method.

4. Costs associated with implementing the Company's Digital Acceleration program.

5. Includes restructuring charges, asset related charges, and costs associated with implementing the Company's 2020 Restructuring Program.

6. Partial reversal of certain asset related reserves recorded in the first quarter of 2022 related to the conflict between Russia and Ukraine.

7. Related to a gain associated with a legal matter with Nova Chemicals Corporation and a gain related to an adjustment of the Dow Silicones breast implant liability.

8. Primarily related to charges associated with agreements entered into with DuPont and Corteva as part of the separation and distribution which, among other matters, provides for cross-indemnities and allocations of obligations and liabilities for periods prior to, at and after the completion of the separation.

9. Related to reversals of certain tax valuation allowances partially offset by charges related to uncertain tax positions.

------

**Dow Inc. and Subsidiaries**

**Selected Financial Information and Non-GAAP Measures**

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Significant Items Impacting Results for the Twelve Months Ended Dec 31, 2022** | **Significant Items Impacting Results for the Twelve Months Ended Dec 31, 2022** | **Significant Items Impacting Results for the Twelve Months Ended Dec 31, 2022** | **Significant Items Impacting Results for the Twelve Months Ended Dec 31, 2022** | **Significant Items Impacting Results for the Twelve Months Ended Dec 31, 2022** |
| In millions, except per share amounts (Unaudited) | *Pretax* <sup>1</sup> | *Net Income* <sup>2</sup> | *EPS* <sup>3</sup> | *Income Statement Classification* |
| Reported results | $6090 | $4582 | $6.28 |  |
| Less: Significant items |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Digitalization program costs <sup>4</sup> | (230) | (183) | (0.25) | Cost of sales ($199 million); R&D ($6 million); SG&A ($25 million) |
| &nbsp;&nbsp;&nbsp;Restructuring, implementation costs and asset related charges - net <sup>5</sup> | (40) | (32) | (0.04) | Cost of sales ($30 million); R&D ($6 million); SG&A ($4 million) |
| &nbsp;&nbsp;&nbsp;Russia / Ukraine conflict charges <sup>6</sup> | (118) | (86) | (0.11) | Restructuring and asset related charges - net |
| &nbsp;&nbsp;&nbsp;&nbsp;Loss on early extinguishment of debt | (8) | (6) | (0.01) | Sundry income (expense) - net |
| &nbsp;&nbsp;&nbsp;Litigation related charges, awards and adjustments <sup>7</sup> | 381 | 288 | 0.40 | Sundry income (expense) - net |
| &nbsp;&nbsp;&nbsp;Indemnifications and other transaction related costs <sup>8</sup> | 4 | 4 | 0.01 | Sundry income (expense) - net |
| &nbsp;&nbsp;&nbsp;&nbsp; Income tax related items |  | 25 | 0.03 | Provision for income taxes on continuing operations |
| &nbsp;&nbsp;&nbsp;&nbsp;Total significant items | $(11) | $10 | $0.03 |  |
| Operating results (non-GAAP) | $6101 | $4572 | $6.25 |  |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Significant Items Impacting Results for the Twelve Months Ended Dec 31, 2021** | **Significant Items Impacting Results for the Twelve Months Ended Dec 31, 2021** | **Significant Items Impacting Results for the Twelve Months Ended Dec 31, 2021** | **Significant Items Impacting Results for the Twelve Months Ended Dec 31, 2021** | **Significant Items Impacting Results for the Twelve Months Ended Dec 31, 2021** |
| In millions, except per share amounts (Unaudited) | *Pretax* <sup>1</sup> | *Net Income* <sup>2</sup> | *EPS* <sup>3</sup> | *Income Statement Classification* |
| Reported results | $8145 | $6311 | $8.38 |  |
| Less: Significant items |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Digitalization program costs <sup>4</sup> | (169) | (132) | (0.17) | Cost of sales ($146 million); R&D ($4 million); SG&A ($19 million) |
| &nbsp;&nbsp;&nbsp;Restructuring, implementation costs and asset related charges - net <sup>5</sup> | (69) | (55) | (0.07) | Cost of sales ($50 million); R&D ($8 million); SG&A ($5 million); Restructuring, goodwill impairment and asset related charges - net ($6 million) |
| &nbsp;&nbsp;&nbsp;&nbsp;Loss on early extinguishment of debt | (574) | (471) | (0.63) | Sundry income (expense) - net |
| &nbsp;&nbsp;&nbsp;&nbsp;Net gain on divestitures and asset sale | 16 | 16 | 0.02 | Sundry income (expense) - net |
| &nbsp;&nbsp;&nbsp;&nbsp;Litigation related charges, awards and adjustments | 54 | 42 | 0.06 | Sundry income (expense) - net |
| &nbsp;&nbsp;&nbsp;Indemnification and other transaction related costs <sup>8</sup> | 30 | 30 | 0.04 | Sundry income (expense) - net |
| &nbsp;&nbsp;&nbsp; Income tax related items <sup>9</sup> |  | 111 | 0.15 | Provision for income taxes on continuing operations |
| &nbsp;&nbsp;&nbsp;&nbsp;Total significant items | $(712) | $(459) | $(0.60) |  |
| Operating results (non-GAAP) | $8857 | $6770 | $8.98 |  |

---

1."Income before income taxes."

2."Net income available for Dow Inc. common stockholders." The income tax effect on significant items was calculated based upon the enacted tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment.

3."Earnings per common share - diluted," which includes the impact of participating securities in accordance with the two-class method.

4. Costs associated with implementing the Company's Digital Acceleration program.

5. Includes restructuring charges, asset related charges, and costs associated with implementing the Company's 2020 Restructuring Program.

6. Asset related charges including inventory write-downs, bad debt reserves, and impairments of other assets related to the conflict between Russia and Ukraine.

7. Related to a gain associated with a legal matter with Nova Chemicals Corporation and a gain related to an adjustment of the Dow Silicones breast implant liability.

8. Primarily related to charges associated with agreements entered into with DuPont and Corteva as part of the separation and distribution which, among other matters, provides for cross-indemnities and allocations of obligations and liabilities for periods prior to, at and after the completion of the separation.

9. Related to reversals of certain tax valuation allowances partially offset by charges related to uncertain tax positions.

------

**Dow Inc. and Subsidiaries**

**Selected Financial Information and Non-GAAP Measures**

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Reconciliation of Free Cash Flow** | *Three Months Ended* | *Three Months Ended* | *Twelve Months Ended* | *Twelve Months Ended* |
| In millions (Unaudited) | *Dec 31, 2022* | *Dec 31, 2021* | *Dec 31, 2022* | *Dec 31, 2021* |
| Cash provided by operating activities - continuing operations (GAAP) | $2078 | $2557 | $7486 | $7069 |
| Capital expenditures | (599) | (466) | (1823) | (1501) |
| Free Cash Flow (non-GAAP) <sup>1</sup> | $1479 | $2091 | $5663 | $5568 |

---

1. Free Cash Flow for the twelve months ended December 31, 2021 reflects a $1 billion elective pension contribution.

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Reconciliation of Cash Flow Conversion** | *Three Months Ended* | *Three Months Ended* | *Three Months Ended* | *Three Months Ended* |
| **Reconciliation of Cash Flow Conversion** | *Mar 31, 2022* | *Jun 30, 2022* | *Sep 30, 2022* | *Dec 31, 2022* |
| In millions (Unaudited) | *Mar 31, 2022* | *Jun 30, 2022* | *Sep 30, 2022* | *Dec 31, 2022* |
| Cash provided by operating activities - continuing operations (GAAP) | $1612 | $1856 | $1940 | $2078 |
| Operating EBITDA (non-GAAP) | $3171 | $3059 | $1863 | $1255 |
| Cash Flow Conversion (Operating EBITDA to cash flow from operations) (non-GAAP) | 50.8% | 60.7% | 104.1% | 165.6% |
| Cash Flow Conversion - trailing twelve months (non-GAAP) |  |  |  | 80.1% |

---

<br>